The Council understands the current widespread concerns regarding the novel coronavirus (COVID-19).
The NSW Ministry of Health has received several confirmed reports of pharmacists being targeted to obtain Schedule 8 drugs fraudulently.
Early in 2020 there will be a number of significant changes to the pharmacy ownership approval process.
Readers may be aware of the outcome of the Australian Health Practitioner Regulatory Agency’s (AHPRA’s) prosecutions of individuals who were working as pharmacists whilst unregistered and the Healt
Fentanyl patches and oxycodone tablets together make up more than 50% of forgeries reported in the last 12 months, with benzodiazepines coming in next, such as alprazolam making up 9%.
Are you a compounding pharmacy who compounds for other stores in your banner group?
As we come into the traditional busy season in pharmacy, the Council has also continued to remain busy with an ever increasing number of notifications.
The 2018/19 Annual Report of the Pharmacy Council of NSW is now available.
The 2018/19 Annual Report is structured in three parts:
The Pharmacy Council of New South Wales is pleased to announce the launch of its Compounding checklist and Premises and equipment guidance for non-sterile complex compounding.